A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliografiska uppgifter
Huvudupphovsman: Islam, Nahidul
Övriga upphovsmän: Talukder, Mesbah
Materialtyp: Lärdomsprov
Språk:English
Publicerad: Brac University 2023
Ämnen:
Psoriasis
Biologics
FAERS
Interleukin inhibitors
Alopecia
Pharmacovigilance
Länkar:http://hdl.handle.net/10361/22025

Internet

http://hdl.handle.net/10361/22025

Liknande verk